The Role and Value of Prescription Digital Therapeutics in Behavioral Disorders

Two experts define prescription digital therapeutics (PDTs) and their role in behavioral care therapy.

Arwen Podesta, MD, provides an overview of how PDTs have evolved over the past 6 years since their introduction into the medical world.

Dr Podesta calls on her experience using PDTs with patients to describe what successes and challenges are common.

Dr Arwen Podesta explains her PDT patient selection process and the factors she considers before treatment.

Medical professionals discuss PDT management, from patient satisfaction and clinical outcomes to cost.

Dr Brixner highlights the important factors a payer must look at when determining PDT coverage, and Dr Podesta comments from the provider perspective.

Two medical experts relay their ideas on how to better improve the payer-provider relationship surrounding PDT use.

Drs Podesta and Brixner discuss possible ways to improve access to PDTs for every party involved—patient, payer, and provider.

Diana Brixner, RPh, PhD, comments on how incorporating value-based pilot programs would impact her decision-making with PDT coverage as a payer.

Our experts conclude by interpreting ways to better educate both payers and providers on PDTs.